Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 16/20 | 0.66 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.50 |
| ▸ | PRKDC | P78527 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6701248 | 1.00 | ATR (0.66) | ATRTLR9PRKDC | |
| SCHEMBL29886432 | 0.91 | ATR (0.57) | ATRPRKDC | |
| SCHEMBL29886145 | 0.91 | ATR (0.57) | ATRPRKDC | |
| SCHEMBL6701889 | 0.90 | ADORA1 (0.56) | ATRPRKDC | |
| SCHEMBL12198431 | 0.90 | ATR (0.56) | ATRPRKDC | |
| SCHEMBL934795 | 0.90 | ADORA1 (0.56) | ATRPRKDC | |
| SCHEMBL29886664 | 0.86 | ATR (0.71) | ATR | |
| SCHEMBL6696565 | 0.86 | ATR (0.57) | ATRPRKDC | |
| SCHEMBL6697532 | 0.86 | ATR (0.57) | ATRPRKDC | |
| SCHEMBL5959065 | 0.85 | NPC1 (0.54) | ATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260077068-A1 | ATP-INDEPENDENT BIOLUMINESCENT REPORTER VARIANTS TO IMPROVE IN VIVO IMAGING | UNIV VIRGINIA PATENT FOUNDATION (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077068-A1 | ATP-INDEPENDENT BIOLUMINESCENT REPORTER VARIANTS TO IMPROVE IN VIVO IMAGING | KCNN2, KCNN1, ATP1B2 | ATR 2600/4885TLR9 4846/4885PRKDC 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.